Skip to content

A research on improving acceptability of Ayurveda medicine

Comparative Clinical Evaluation of Nano dosage form in the Management of Dermatological Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009419
Enrollment
60
Registered
2017-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Psoriasis Eczema

Interventions

Intervention1: Guggulu Tiktha Grutha in nano encapsulated form: Guggulu Tiktha Grutha of Kottakal Ayurveda Pharmacy Mysuru unit will be purchased for the study and Sodium Caseinate from Sigma Aldrich

Sponsors

RGUHS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender with in the age group of 16-50 years, attending OPD at JSS Ayurveda Hospital with clinical diagnosis of psoriasis and eczema will be selected.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women and patients with other systemic disorders such as diabetes, hypertension, heart diseases and patients with infectious diseases will be excluded.

Design outcomes

Primary

MeasureTime frame
Assessment on whether macro dose of medicated ghee be concised to micro dose through nano encapsulationTimepoint: 6 Months

Secondary

MeasureTime frame
Assessment of clinical efficacy of nano encapsulated dosage of GTG similar to conventional dosage formTimepoint: One and half year

Countries

India

Contacts

Public ContactDR KRISHNA PRASAD N
krishna.ayur@gmail.com9980656297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026